"Anthroposophic Therapies in Chrnoic Disease: the Anthroposophic Medicine Outcomes Study (AMOS)", European Journal of Medical Research (2004) 9: 351-360
"Substantial, consistent and stable improvements of disease symptoms and HRQoL were observed during the 2-year follow-up."
"In this study anthroposophic therapies were associated with substantial long-term reduction of disease severi- ty and improvement of health-related quality of life in patients with musculoskeletal and mental disorders, headache syndromes, asthma and other chronic dis- eases. Considering the long disease duration before en- rolment (average 6 ½ years), these results are encour- aging. The favourable outcomes were associated with a low frequency of adverse effects and were not accom- panied by an increase in health costs. "
Anthroposophic vs. conventional therapy of acute respiratory and ear infections: a prospective outcomes study, Wiener Klinische Wochenschrift 2005, 117(7-8): 256-268
Harald J. Hamre1, Michael Fischer2, Marianne Heger3, David Riley4, Max Haidvogl5,Erik Baars6, Eileen Bristol7, Michael Evans8, Reinhard Schwarz9, Helmut Kiene1
1: Institute for Applied Epistemology and Medical Methodology, Freiburg, Germany 2: ClinResearch GmbH, Cologne, Germany 3: Research Center HomInt, Karlsruhe, Germany 4: University of New Mexico School of Medicine and Integrative Medicine Institute, Santa Fe, New Mexico, USA 5: Ludwig Boltzmann Institute for Homeopathy, Graz, Austria 6: Louis Bolk Instituut, Driebergen, The Netherlands 7: Ann Arbor, Michigan, USA 8: Stroud, UK 9: Graz, Austria
" Study results suggest that anthroposophic treatment of primary care patients with acute respiratory and ear infections is safe and at least as effective as conventional treatment."
Gunver Kienle MD, Helmut Kiene MD, Hans Ulrich Albonico, MD, Anthroposophic Medicine Effectiveness, Utility, Costs Safety ; Reviewers, Institute for Applied Epistemology and Medical Methodology IFAEMM, Schauinslandstrasse 6, DE-70189 Bad Krozingen. Schattauer Verlag, Stuttgart-New York (Schattauer GmbH, Hölderlinstrasse3, DE-70174, Stuttgart, Germany). ISBN-10: 3-7945-2495-0 ISBN-13: 978-3-7945-2495-2
In a comprehensive review of studies of anthroposophic medicine (AM): " 195 studies were analysed: 186 studies had positive results for the AM-Group (similar or better result compared to conventional therapy regarding at least 1 clinical parameter). 8 studies showed neither positive nor negative results. 1 study showed a negative trend. The practical relevance was throughout the studies high. The quality of the studies varied from very to good to very poor (in particular the retrospective comparative studies). The satisfaction of the patients was high. The positive results were still relevant, if the analysis was restricted to the qualitatively good studies."
"Anthroposophic Art Therapy in Chronic Disease: A Four-Year Prospective Cohort Study". EXPLORE: The Journal of Science and Healing , Volume 3 , Issue 4 , Pages 365 - 371 H . Hamre , C . Witt , A . Glockmann , R . Ziegler , S . Willich , H . Kiene
"Most common indications were mental disorders (60.9% of patients, primarily depression, fatigue, and anxiety) and neurological diseases (6.8%). The median number of therapy sessions was 15; median therapy duration was 161 days. All outcomes except KINDL improved significantly between baseline and all subsequent follow-ups. Improvements from baseline to 12 months were: disease score from (mean ± standard deviation) 6.69 ± 1.72 to 2.46 ± 1.90 (P < .001), symptom score from 5.99 ± 1.69 to 3.40 ± 2.08 (P < .001), SF-36 physical component summary measure from 44.12 ± 10.03 to 48.68 ± 9.47 (P < .001), and SF-36 mental component summary measure from 35.07 ± 12.23 to 42.13 ± 11.51 (P < .001). All these improvements were maintained until last follow-up."
Conclusion "Patients receiving anthroposophic art therapy had long-term reduction of chronic disease symptoms and improvement of quality of life."
"Anthroposophic therapy for chronic depression: a four-year prospective cohort study" BMC Psychiatry. 2006; 6: 57.
Harald J Hamre, 1 Claudia M Witt,2 Anja Glockmann,1 Renatus Ziegler,3 Stefan N Willich,2 and Helmut Kiene1 1Institute for Applied Epistemology and Medical Methodology, Böcklerstr. 5, 79110 Freiburg, Germany 2Institute of Social Medicine, Epidemiology, and Health Economics, Charité University Medical Center, Campus Mitte, 10098 Berlin, Germany 3Society for Cancer Research, Kirschweg 9, 4144 Arlesheim, Switzerland Corresponding author.
Published online 2006 December 15. doi: 10.1186/1471-244X-6-57. PMC 1764730
"In outpatients with chronic depression, anthroposophic therapies were followed by long-term clinical improvement."
"Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis", Eur J Med Res (2006) 11: 485-495
"Anthroposophic Therapies in Chrnoic Disease: the Anthroposophic Medicine Outcomes Study (AMOS)", European Journal of Medical Research (2004) 9: 351-360
"Substantial, consistent and stable improvements of disease symptoms and HRQoL were observed during the 2-year follow-up."
"In this study anthroposophic therapies were associated with substantial long-term reduction of disease severi- ty and improvement of health-related quality of life in patients with musculoskeletal and mental disorders, headache syndromes, asthma and other chronic dis- eases. Considering the long disease duration before en- rolment (average 6 ½ years), these results are encour- aging. The favourable outcomes were associated with a low frequency of adverse effects and were not accom- panied by an increase in health costs. "
Anthroposophic vs. conventional therapy of acute respiratory and ear infections: a prospective outcomes study, Wiener Klinische Wochenschrift 2005, 117(7-8): 256-268
Harald J. Hamre1, Michael Fischer2, Marianne Heger3, David Riley4, Max Haidvogl5,Erik Baars6, Eileen Bristol7, Michael Evans8, Reinhard Schwarz9, Helmut Kiene1
1: Institute for Applied Epistemology and Medical Methodology, Freiburg, Germany 2: ClinResearch GmbH, Cologne, Germany 3: Research Center HomInt, Karlsruhe, Germany 4: University of New Mexico School of Medicine and Integrative Medicine Institute, Santa Fe, New Mexico, USA 5: Ludwig Boltzmann Institute for Homeopathy, Graz, Austria 6: Louis Bolk Instituut, Driebergen, The Netherlands 7: Ann Arbor, Michigan, USA 8: Stroud, UK 9: Graz, Austria
" Study results suggest that anthroposophic treatment of primary care patients with acute respiratory and ear infections is safe and at least as effective as conventional treatment."
Gunver Kienle MD, Helmut Kiene MD, Hans Ulrich Albonico, MD, Anthroposophic Medicine Effectiveness, Utility, Costs Safety ; Reviewers, Institute for Applied Epistemology and Medical Methodology IFAEMM, Schauinslandstrasse 6, DE-70189 Bad Krozingen. Schattauer Verlag, Stuttgart-New York (Schattauer GmbH, Hölderlinstrasse3, DE-70174, Stuttgart, Germany). ISBN-10: 3-7945-2495-0 ISBN-13: 978-3-7945-2495-2
In a comprehensive review of studies of anthroposophic medicine (AM): " 195 studies were analysed: 186 studies had positive results for the AM-Group (similar or better result compared to conventional therapy regarding at least 1 clinical parameter). 8 studies showed neither positive nor negative results. 1 study showed a negative trend. The practical relevance was throughout the studies high. The quality of the studies varied from very to good to very poor (in particular the retrospective comparative studies). The satisfaction of the patients was high. The positive results were still relevant, if the analysis was restricted to the qualitatively good studies."
"Anthroposophic Art Therapy in Chronic Disease: A Four-Year Prospective Cohort Study". EXPLORE: The Journal of Science and Healing , Volume 3 , Issue 4 , Pages 365 - 371 H . Hamre , C . Witt , A . Glockmann , R . Ziegler , S . Willich , H . Kiene
"Most common indications were mental disorders (60.9% of patients, primarily depression, fatigue, and anxiety) and neurological diseases (6.8%). The median number of therapy sessions was 15; median therapy duration was 161 days. All outcomes except KINDL improved significantly between baseline and all subsequent follow-ups. Improvements from baseline to 12 months were: disease score from (mean ± standard deviation) 6.69 ± 1.72 to 2.46 ± 1.90 (P < .001), symptom score from 5.99 ± 1.69 to 3.40 ± 2.08 (P < .001), SF-36 physical component summary measure from 44.12 ± 10.03 to 48.68 ± 9.47 (P < .001), and SF-36 mental component summary measure from 35.07 ± 12.23 to 42.13 ± 11.51 (P < .001). All these improvements were maintained until last follow-up."
Conclusion "Patients receiving anthroposophic art therapy had long-term reduction of chronic disease symptoms and improvement of quality of life."
"Anthroposophic therapy for chronic depression: a four-year prospective cohort study" BMC Psychiatry. 2006; 6: 57.
Harald J Hamre, 1 Claudia M Witt,2 Anja Glockmann,1 Renatus Ziegler,3 Stefan N Willich,2 and Helmut Kiene1 1Institute for Applied Epistemology and Medical Methodology, Böcklerstr. 5, 79110 Freiburg, Germany 2Institute of Social Medicine, Epidemiology, and Health Economics, Charité University Medical Center, Campus Mitte, 10098 Berlin, Germany 3Society for Cancer Research, Kirschweg 9, 4144 Arlesheim, Switzerland Corresponding author.
Published online 2006 December 15. doi: 10.1186/1471-244X-6-57. PMC 1764730
"In outpatients with chronic depression, anthroposophic therapies were followed by long-term clinical improvement."
"Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis", Eur J Med Res (2006) 11: 485-495